Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Product Registration Regime Chokes China Supplement Industry Growth

This article was originally published in The Tan Sheet

Executive Summary

The U.S.-China Health Products Association says China is considering reforms to the country’s food product industry regulations. Relaxing the supplement registration requirement would increase demand for Chinese suppliers’ ingredients from firms that would sell more of their finished products in the country.

You may also be interested in...



Herbalife Under SEC Scrutiny On Regulatory Compliance In China

Herbalife is the focus of a Securities and Exchange Commission investigation into anti-corruption compliance in the firm’s China business, the company reported in a Jan. 20 regulatory filing. An analyst covering the stock believes the investigation will have little impact on growth.

FDA NDI Draft Is A Push For Tighter Supplement Regulation – Stakeholders

FDA proposed “a pretty crazy” NDI notification draft guidance, says attorney Wes Siegner, because “they think everything is an NDI.” Other stakeholders acknowledge FDA wants tighter regulation of the industry, but say writing and imposing rules for supplement manufacturing is a two-way street.

China Market Veteran Crowther Lobbies For Nutritional Product Regs

The U.S.-China Health Products Association is pushing China's regulators to publish health food regulations to help spur Western firms' entry into the country.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel